Importantly, we demonstrated that primitive AML cells significantly overexpress IL1RAP compared to normal BM-derived HSCs, suggesting that IL1RAP targeting could potentially spare normal BM HSCs. This evidence concerns the gene IL1RAP and acute myeloid leukemia.